News | May 03, 2025
Zydus Lifesciences completes 25 years of listing on NSE
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
The Q1 2025 also witnessed a successful launch of Allegra D
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
The Board has also approved plans to invest approximately Rs. 500 crores including cost of land in developing a state-of-the-art, 400-bed super specialty hospital
Delivers robust earnings performance, successfully navigating a dynamic environment
Trastuzumab specifically binds and inhibits the human epidermal growth factor receptor 2 (HER2) protein
Distribution agreement enables FUJIFILM India to offer Spectra Logic advanced tape libraries and software solutions to enterprise customers and channel partners
Bayer expects 2025 to be the most difficult year of its turnaround
Syngene reported revenue growth of 11% year-on-year, and 8% sequentially crossing the Rs. 1,000 Cr in a quarter threshold for the first time
Subscribe To Our Newsletter & Stay Updated
